Lenskart Approves Stock Option Plans and Loan Conversions for Subsidiaries
Lenskart's Board approved the Lenskart Employee Stock Option Plan, 2021, allowing up to 2,60,40,528 options, and Plan-2025, allowing up to 7,280,431 options. The company also approved converting inter-company loans into equity for its subsidiaries, Lenskart Singapore and NESO Brands, to address their financial difficulties.
The approval of employee stock option plans can impact future share dilution and employee motivation. The conversion of loans to equity for subsidiaries addresses potential financial strain and operational restructuring, which could have a medium-term impact on the company's financial health and reporting.
The announcement details the approval of employee stock option plans and the conversion of inter-company loans to equity for subsidiaries. While these are standard corporate actions, they do not immediately suggest a significant positive or negative financial impact.
Lenskart Solutions Limited's Board of Directors, in a meeting held on February 11, 2026, approved key strategic decisions including the ratification of the Lenskart Employee Stock Option Plan, 2021, and the Lenskart Employee Stock Option Plan, 2025. The Plan, 2021, will be implemented through the direct route, allowing for the grant of up to 2,60,40,528 Employee Stock Options exercisable into equity shares of face value ₹2 each. The exercise price will be based on the average closing price for 30 days prior to the grant, with a maximum discount of 25%. Vesting will occur between two to four years from the grant date.
The Plan-2025 will be implemented through the Trust Route, with a primary mode of acquisition being secondary acquisition from the market. This plan allows for the grant of up to 7,280,431 Employee Stock Options, also exercisable into equity shares of face value ₹2 each, with a similar pricing formula and a vesting period of one to five years.
Both plans will extend benefits to eligible employees of the Company, including its group, subsidiary, and associate companies, both in India and outside India. Additionally, the Board approved the conversion of pre-existing inter-company loans into equity for its wholly-owned overseas subsidiaries, Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd. This conversion is intended to address the inability of these entities to service their loan obligations due to their loss-making status. Lenskart Singapore Pte. Ltd. reported a turnover of SGD 30,046,932 in FY25, while NESO Brands Pte. Ltd. had nil turnover and a negative net worth of SGD (2,899,074) as of March 31, 2025. The board meeting commenced at 1:00 PM IST and concluded at 03:26 PM IST.
What to do with a filing like this
Lenskart Solutions Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lenskart Solutions Limited. Read the original for the full detail.